Oxitec, the Abingdon-based specialist in modifying insect pests to less economically damaging forms, has appointed a former UK Zeneca executive as chief executive. Oxitec is a division of the US Intrexon Corp.
Dr Mark Carnegie-Brown will succeed Hadyn Parry at Oxitec after the latter’s promotion to vice president corporate development Europe, the Middle East, and Africa for Intrexon. Dr Carnegie-Brown was general manager of Zeneca’s agrochemical business in the UK and Ireland where he developed and implemented a cutting edge value chain strategy and drove transformation toward an organization attuned to consumers. Zeneca was merged into Syngenta in 2000. He was most recently chief executive of Glide Technologies which developed a therapeutic delivery platform.
“I am delighted to be joining Oxitec and look forward to advancing its pioneering solutions including Friendly Aedes,” Dr Carnegie-Brown states. “I believe the company’s technology represents a paradigm shift in controlling both disease-carrying insects, including dangerous Aedes aegypti mosquitoes and damaging agricultural pests that are increasingly resistant to chemical insecticides.”